Clinical trial
An Open-Label Biomarker Study of ATH434 in Multiple System Atrophy
NCT05864365 is registered in ClinicalTrials.gov with Alterity Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Biomarker Study of ATH434 in Multiple System Atrophy
- Lead sponsor
- Alterity Therapeutics
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 23, 2023
- Completion date
- February 26, 2025
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.